male scientist
Medicines

Transforming Ideas Into Treatments

Our passion for patients in need fuels our dedication to fill the therapeutic void with potential for the future. With RNA as the basis of our discovery platform, we are able to bring therapeutic options to patients who otherwise would have limited or no options.

Ionis has discovered and developed marketed medicines for serious diseases, including breakthrough medicines for neurologic and cardiometabolic diseases.

Image
Hibsago Logo
HIBSAGO™

HIBSAGOTM is marketed by GSK. For more information about HIBSAGO and U.S. prescribing information, visit HIBSAGO.com.

Image
Qalsody (tofersen) Logo
QALSODY®

QALSODY® is marketed by Biogen. For more information about QALSODY and U.S. prescribing information, visit QALSODY.com.

Image
Spinraza logo
SPINRAZA®

SPINRAZA® is marketed by Biogen. For more information about SPINRAZA and U.S. prescribing information, visit SPINRAZA.com.

Image
Wainua (eplontersen) Logo
WAINUA™

WAINUA™ is marketed by AstraZeneca. For more information about WAINUA and U.S. prescribing information, visit WAINUA.com.

US-ABR-2400001 v8 11/2026

Image
man smiling with group
Ionis Every Step™
Let's take this step by step, together
Ionis Every Step™ provides resources and personal support at every step to get you started on your Ionis medication quickly and confidently.
View our Clinical Pipeline
We are relentlessly pursuing the innovations of tomorrow with our broad and diverse pipeline of potential first or best-in-class investigational therapies designed to treat a range of diseases. Learn more about our pipeline.